Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Longevity
Synthetic pineal tetrapeptide that activates telomerase and modulates melatonin production.
Peptide B
Longevity
D-retro-inverso senolytic peptide — selectively kills senescent cells via FOXO4-p53 disruption.
Typical vial
10 mg
Typical dose
5000-10000 mcg
Half-life
~30 minutes (short half-life but biological effects persist due to gene expression changes)
FDA status
Not FDA approved for human use. No clinical trials submitted…
Typical vial
10 mg
Typical dose
Per kg dosing (research) mcg
Half-life
Extended via DRI backbone (~hours-days)
FDA status
Not FDA approved. In preclinical / early clinical developmen…
Epithalon effects
FOX04-DRI effects
Epithalon side effects
FOX04-DRI side effects
Epithalon dosing ranges
Anti-aging and telomere support
5-10 mg · Once daily (SubQ) · 10-20 days, repeated 1-2 times per year
FOX04-DRI dosing ranges
Senolytic research (research-only)
0.4-5 mg/kg · Every other day for 1-2 weeks per cycle · Cycle-based per protocol
Epithalon: Synthetic pineal tetrapeptide that activates telomerase and modulates melatonin production. Typical dose 5000-10000 mcg. FOX04-DRI: D-retro-inverso senolytic peptide — selectively kills senescent cells via FOXO4-p53 disruption. Typical dose Per kg dosing (research) mcg. Both fall under the Longevity category.
Stacking Epithalon with FOX04-DRI is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
Epithalon is typically dosed: Once daily (SubQ) for Anti-aging and telomere support. FOX04-DRI is typically dosed: Every other day for 1-2 weeks per cycle for Senolytic research (research-only).
Epithalon: Not FDA approved for human use. No clinical trials submitted to the FDA. FOX04-DRI: Not FDA approved. In preclinical / early clinical development as Proxofim (Cleara Biotech).
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free